Notice of General Meeting

Plant Health Care PLC
12 June 2024
 

12 June 2024                                  

 

Plant Health Care plc

 ("Plant Health Care" or the "Company")

 

Notice of General Meeting

Plant Health Care® (AIM.PHC.L), a leading provider of peptides used by growers to improve crop production and quality within global agriculture markets, announces that a Notice convening a General Meeting of Shareholders (the "GM") has been mailed to shareholders and available on the Company's website at www.planthealthcare.com.

The GM is to be held at the offices of Cavendish Capital Markets Limited, One Bartholomew Close, London, EC1A 7BL on 28 June 2024 at 9:30 a.m., immediately prior to the Company's Annual General Meeting, and is being convened for technical purposes to ensure that the directors are re-elected as required in accordance with the Company's Articles of Association.

For further information, please contact:
 

Plant Health Care plc
Jeff Tweedy, CEO

 

Tel: +1 919 926 1600

 

 

Cavendish Capital Markets Limited - Nomad & Broker
Neil McDonald / Pete Lynch

 

Tel: +44 (0) 131 220 9771

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, sugarcane, potatoes, rice, and wheat, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors, and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings